For: | Liang JJ, Feng WJ, Li R, Xu RT, Liang YL. Analysis of the value and safety of thyroid-stimulating hormone in the clinical efficacy of patients with thyroid cancer. World J Clin Cases 2023; 11(5): 1058-1067 [PMID: 36874431 DOI: 10.12998/wjcc.v11.i5.1058] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v11/i5/1058.htm |
Number | Citing Articles |
1 |
L. ZHU, B-C. AHN. Natural Killer Cell-Derived Exosome Mimetics as Natural Nanocarriers for In Vitro Delivery of Chemotherapeutics to Thyroid Cancer Cells. Experimental Oncology 2025; 46(4): 358 doi: 10.15407/exp-oncology.2024.04.358
|
2 |
Mei Guo, Yuqi Sun, Yuyao Wei, Jianxin Xu, Chun Zhang. Advances in targeted therapy and biomarker research in thyroid cancer. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1372553
|